6:18 PM
Nov 28, 2006
 |  BC Extra  |  Company News

Eli Lilly, Applied NeuroSolutions in AD deal

LLY and APNS partnered to develop therapeutics to treat Alzheimer's disease. LLY will have exclusive rights to APNS's IP related to the...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >